140 related articles for article (PubMed ID: 27281790)
1. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
[TBL] [Abstract][Full Text] [Related]
2. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
[TBL] [Abstract][Full Text] [Related]
3. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
Benedikt C; Kelly SL; Wilson D; Wilson DP;
Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
[TBL] [Abstract][Full Text] [Related]
4. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
[TBL] [Abstract][Full Text] [Related]
5. Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study.
Rautenbach SP; Whittles LK; Meyer-Rath G; Jamieson L; Chidarikire T; Johnson LF; Imai-Eaton JW
Lancet Public Health; 2024 Apr; 9(4):e218-e230. PubMed ID: 38553141
[TBL] [Abstract][Full Text] [Related]
6. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.
Fraser N; Kerr CC; Harouna Z; Alhousseini Z; Cheikh N; Gray R; Shattock A; Wilson DP; Haacker M; Shubber Z; Masaki E; Karamoko D; Görgens M
J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S213-20. PubMed ID: 25723987
[TBL] [Abstract][Full Text] [Related]
7. The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there.
Stuart RM; Fraser-Hurt N; Kerr CC; Mabusela E; Madi V; Mkhwanazi F; Pillay Y; Barron P; Muzah B; Matsebula T; Gorgens M; Wilson DP
J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29359533
[TBL] [Abstract][Full Text] [Related]
8. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
[TBL] [Abstract][Full Text] [Related]
9. Economic analysis of HIV prevention interventions in Andhra Pradesh state of India to inform resource allocation.
Dandona L; Kumar SG; Kumar GA; Dandona R
AIDS; 2009 Jan; 23(2):233-42. PubMed ID: 19112690
[TBL] [Abstract][Full Text] [Related]
10. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
[TBL] [Abstract][Full Text] [Related]
11. Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations.
Craig AP; Thein HH; Zhang L; Gray RT; Henderson K; Wilson D; Gorgens M; Wilson DP
J Int AIDS Soc; 2014; 17(1):18822. PubMed ID: 24572053
[TBL] [Abstract][Full Text] [Related]
12. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
[TBL] [Abstract][Full Text] [Related]
13. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
[TBL] [Abstract][Full Text] [Related]
14. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF
Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587
[TBL] [Abstract][Full Text] [Related]
15. Estimating prevalence and modelling correlates of HIV test positivity among female sex workers, men who have sex with men, people who inject drugs, transgender people and prison inmates in Sierra Leone, 2021.
Dwomoh D; Wurie I; Harding Y; Sedzro KM; Kandeh J; Tagoe H; Addo C; Arhinful DK; Sessay ARC; Kamara JL; Mansaray K; Ampofo WK
AIDS Res Ther; 2023 Sep; 20(1):70. PubMed ID: 37759241
[TBL] [Abstract][Full Text] [Related]
16. Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.
Cepeda JA; Bórquez A; Magana C; Vo A; Rafful C; Rangel G; Medina-Mora ME; Strathdee S; Martin NK
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25493. PubMed ID: 32562375
[TBL] [Abstract][Full Text] [Related]
17. The size and distribution of key populations at greater risk of HIV in Pakistan: implications for resource allocation for scaling up HIV prevention programmes.
Emmanuel F; Thompson LH; Salim M; Akhtar N; Reza TE; Hafeez H; Ahmed S; Blanchard JF
Sex Transm Infect; 2013 Sep; 89 Suppl 2(Suppl 2):ii11-7. PubMed ID: 23843454
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
Bernard CL; Owens DK; Goldhaber-Fiebert JD; Brandeau ML
PLoS Med; 2017 May; 14(5):e1002312. PubMed ID: 28542184
[TBL] [Abstract][Full Text] [Related]
19. A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya.
Musyoki H; Bhattacharjee P; Sabin K; Ngoksin E; Wheeler T; Dallabetta G
J Int AIDS Soc; 2021 Jul; 24 Suppl 3(Suppl 3):e25729. PubMed ID: 34189847
[TBL] [Abstract][Full Text] [Related]
20. HIV Treatment and Prevention: A Simple Model to Determine Optimal Investment.
Juusola JL; Brandeau ML
Med Decis Making; 2016 Apr; 36(3):391-409. PubMed ID: 26369347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
